Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea

Author： Tutaeva V.   Misurin A. V.   Michiels J. J.   Rozenberg J. M.   Sokolova M. A.   Ivanova V. L.   Kolosheinova T. I.   Manakova T. E.   Levina A. A.   Semenova E. A.   Khoroshko N. D.  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.12, Iss.6, 2007-12, pp. : 473-479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F

By Steimle C.   Lehmann U.   Temerinac S.   Goerttler Ph.   Kreipe H.   Meinhardt G.   Heimpel H.   Pahl H.  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 239-244

Springer Publishing Company

Access to resources Recommend Favorite

Different involvement of the megakaryocytic lineage by the JAK2V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis

By Hussein Kais   Brakensiek Kai   Buesche Guntram   Buhr Thomas   Wiese Birgitt   Kreipe Hans   Bock Oliver  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 245-253

Springer Publishing Company

Access to resources Recommend Favorite

Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden

By Larsen Thomas Stauffer   Pallisgaard Niels   de Stricker Karin   Møller Michael Boe   Hasselbalch Hans Carl  

Hematology, Vol. 14, Iss. 1, 2009-02 ,pp. : 11-15

Maney Publishing

Access to resources Recommend Favorite

Detection of the JAK2 V617F mutation in patients with slightly elevated platelets or hemoglobin without a secondary cause

By Strobbe Leonie  

Annals of Hematology, Vol. 86, Iss. 11, 2007-11 ,pp. : 801-803

Springer Publishing Company

Access to resources Recommend Favorite

PRV-1 mRNA expression discriminates two types of essential thrombocythemia

By Griesshammer M.  

Annals of Hematology, Vol. 83, Iss. 6, 2004-06 ,pp. : 364-370

Springer Publishing Company

Access to resources Recommend Favorite